Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mackey

Showing results (341-350 of 411) with videos related to

Pageof 42
Sort By:
Scientific Reports|February 18, 2016
Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistanceRaie T Bekele, Ganesh Venkatraman, Rong-Zong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancersJohn R Mackey, Lori L Jennings, Marilyn L Clarke, et al.
Cancer Treatment Reviews|February 28, 2012
Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trialsJohn R Mackey, Robert S Kerbel, Karen A Gelmon, et al.
American Journal of Physiology. Renal Physiology|April 6, 2007
Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidneyVijaya L Damaraju, Adam N Elwi, Charlene Hunter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Cardiopulmonary function and age-related decline across the breast cancer survivorship continuumLee W Jones, Kerry S Courneya, John R Mackey, et al.
The British Journal of Nutrition|December 1, 2022
Rationale and design of IMPACT-women: a randomised controlled trial of the effect of time-restricted eating, healthy eating and reduced sedentary behaviour on metabolic health during chemotherapy for early-stage breast cancerRebecca A G Christensen, Mark J Haykowsky, Michelle Nadler, et al.
Cancer|October 6, 2021
Nighttime compression supports improved self-management of breast cancer-related lymphedema: A multicenter randomized controlled trialMargaret L McNeely, Naomi D Dolgoy, Bolette Skjodt Rafn, et al.
Cancer|February 29, 2008
Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trialKerry S Courneya, Donald C McKenzie, John R Mackey, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|February 21, 2016
Motivation for Different Types and Doses of Exercise During Breast Cancer Chemotherapy: a Randomized Controlled TrialKerry S Courneya, Roanne J Segal, James R Vallerand, et al.
Leukemia & Lymphoma|May 3, 2008
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative studyRaymond Lai, Nancy L Bartlett, John R Mackey, et al.
Pageof 42

Showing results (341-350 of 411) with videos related to

Sort By:
Pageof 42
Scientific Reports|February 18, 2016
Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistanceRaie T Bekele, Ganesh Venkatraman, Rong-Zong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancersJohn R Mackey, Lori L Jennings, Marilyn L Clarke, et al.
Cancer Treatment Reviews|February 28, 2012
Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trialsJohn R Mackey, Robert S Kerbel, Karen A Gelmon, et al.
American Journal of Physiology. Renal Physiology|April 6, 2007
Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidneyVijaya L Damaraju, Adam N Elwi, Charlene Hunter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Cardiopulmonary function and age-related decline across the breast cancer survivorship continuumLee W Jones, Kerry S Courneya, John R Mackey, et al.
The British Journal of Nutrition|December 1, 2022
Rationale and design of IMPACT-women: a randomised controlled trial of the effect of time-restricted eating, healthy eating and reduced sedentary behaviour on metabolic health during chemotherapy for early-stage breast cancerRebecca A G Christensen, Mark J Haykowsky, Michelle Nadler, et al.
Cancer|October 6, 2021
Nighttime compression supports improved self-management of breast cancer-related lymphedema: A multicenter randomized controlled trialMargaret L McNeely, Naomi D Dolgoy, Bolette Skjodt Rafn, et al.
Cancer|February 29, 2008
Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trialKerry S Courneya, Donald C McKenzie, John R Mackey, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|February 21, 2016
Motivation for Different Types and Doses of Exercise During Breast Cancer Chemotherapy: a Randomized Controlled TrialKerry S Courneya, Roanne J Segal, James R Vallerand, et al.
Leukemia & Lymphoma|May 3, 2008
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative studyRaymond Lai, Nancy L Bartlett, John R Mackey, et al.
Pageof 42